Ironwood Pharma Revenue, Profits - IRWD Quarterly Income Statement

Add to My Stocks
$17.29 $0.2 (1.17%) IRWD stock closing price Sep 18, 2018 (Closing)

IRWD stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Ironwood Pharma stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for IRWD which shows a YOY revenue growth of 17.28% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The Ironwood Pharma profit and loss statement for 2018 Q2 shows a net profit of $-49.38M. Profits for last year was $-43.14M. Apart from this an investor should also check Ironwood Pharma assets and Ironwood Pharma free cash flow.

View and download details of revenue and profits for Ironwood Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Ironwood Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)4.07M2.6M8.98M6.08M3.5M-1.86M---
Ironwood Pharma Gross Profit
Research & Development Expense38.93M36.5M40.12M37.06M37.34M33.7M38.45M37.52M31.68M31.84M
Selling General & Admin Expense74.55M62.43M18.88M61.21M64.82M57.21M56.76M53.65M36.91M36.16M
Income Before Depreciation Depletion Amortization-36.44M-32.39M26.23M-17.53M-40.59M-39.28M-9.6M-25.07M-14.25M-1.96M
Depreciation Depletion Amortization3.48M3.47M3.48M1.89M---3.29M3.21M1.06M-
Non Operating Income-0.08M1.99M-1.48M-3.72M5.83M-3.81M2.45M4.84M3.44M-1.42M
Interest Expense9.38M9.27M9.22M9.13M9.04M8.98M9.67M9.76M9.82M9.9M
Ironwood Pharma Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-49.38M-43.14M12.09M-32.3M-44.22M-52.5M-13.51M-33.2M-21.7M-13.3M
Extraordinary Items & Discontinued Operations----------
Ironwood Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS152.16M151.01M149.88M149.5M148.78M147.79M146.27M144.37M144.64M143.59M
Average Shares used to compute Basic EPS152.16M151.01M149.88M149.5M148.78M147.79M146.27M144.37M144.64M143.59M
Income Before Nonrecurring Items-43.13M-40.47M-21.58M-26.7M-42.21M-48.27M-17.74M-25.87M-23.78M-11.65M
Income from Nonrecurring Items-6.25M-2.67M33.66M-5.6M-2.02M-4.23M4.24M-7.34M2.08M-1.64M
Ironwood Pharma Earnings Per Share Basic Net
Ironwood Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.28-0.27-0.14-0.18-0.28-0.33-0.12-0.18-0.16-0.08
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Ironwood Pharma stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that IRWD stock has a topline or revenue of $81.11M for 2018 Q2 as per this Ironwood Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-49.38M for IRWD stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The IRWD financials along with Ironwood Pharma historical stock prices provide a lot of details about the firm.

Ironwood Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield